EUVIMEDEUVIMED entdecken
Open Access

TPGS-stabilized pyrimethamine micelles promote ROS-associated apoptosis in MDA-MB-231 cells and suppress tumour progression in a murine lymphoma model

Indrajeet Yadav, Manisha Nidhar iD, Pavan Goud, Surya Nath Pandey, Amit Patel, Ashish Kumar Tewari, Priyanka Sonker

DARU Journal of Pharmaceutical Sciences · 2026

DOI: 10.1007/s40199-026-00656-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, 2026. Verfasst von Indrajeet Yadav und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Institute of Technology and Management, GIDA, Gorakhpur, Uttar Pradesh, 273209, India. Hauptthemen laut MEDLINE: Pyrimethamine, Vitamin E, Antineoplastic Agents, Lymphoma. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A dihydrofolate reductase inhibitor, pyrimethamine has an emerging anticancer potential but is not well soluble in aqueous and bioavailable. The D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS)-based micellar nanoformulation was developed to overcome these challenges to improve its therapeutic performance.

Objective

The D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS)-based micellar nanoformulation was developed to overcome these challenges to improve its therapeutic performance.

Methods

TPGS micelles containing pyrimethamine were developed through solvent casting-rehydration and studied through DLS, AFM, SEM and TEM.

Results

The maximally efficient expression generated homogeneous spherical micelles with an average diameter of about 74 nm and a low polydispersity (0.20) that is very homogeneous and stable. Persistent bi-phasic drug delivery was seen in physiological conditions. TPGS-Stabilized Pyrimethamine Micelles Promote ROS-Associated Apoptosis. In MDA-MB-231 breast cancer cells, the nanoformulation increased cytotoxicity and intracellular uptake compared with free pyrimethamine. The experiment showed that in mechanistic studies, there was high production of reactive oxygen species, high Annexin V-positive populations of apoptotic cells and G2/M phase arrest, which were associated with increased ROS generation, apoptosis, and cell-cycle arrest. In the murine lymphoma model, the nanoformulation reduced tumour progression and resulted in 100% survival through Day 30.

Conclusion

These findings support further preclinical investigation of TPGS-based pyrimethamine micelles as a potential anticancer delivery strategy. Additional studies are required to confirm their mechanism, pharmacokinetic behaviour, long-term safety, and efficacy in breast-cancer-specific animal models. Graphical Abstract TPGS–pyrimethamine micelles enhance cellular uptake and are associated with increased ROS generation, apoptosis, and cell-cycle alterations in MDA-MB-231 cells, together with tumour suppression in a murine lymphoma model

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimethamineVitamin EAntineoplastic AgentsLymphomaMicellesAnimalsApoptosisReactive Oxygen SpeciesHumansMiceFemaleCell Line, TumorMice, Inbred BALB C

Stichwörter der Autor:innen

ApoptosisCell-cycle arrestMDA-MB-231 cellsMurine lymphoma modelNanomedicinePyrimethamineReactive oxygen speciesTPGS micelles

Substanzen

PyrimethamineMicellesReactive Oxygen SpeciestocophersolanVitamin EAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Institute of Technology and Management, GIDA, Gorakhpur, Uttar Pradesh, 273209, India.
  • Center for innovation and inclusive research, Sharda University, 201306, Greater Noida, India.
  • Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, India.
  • Department of Pharmacology, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, 244001, Moradabad, India.
  • Banaras Hindu University, Varanasi, India.
  • Department of Pharmacy, Institute of Technology and Management, GIDA, Gorakhpur, Uttar Pradesh, 273209, India. priyankasonker2016@gmail.com.

ORCID-Profile: Manisha Nidhar

Zitieren

APA

Yadav, I., Nidhar, M., Goud, P., Pandey, S. N., Patel, A., Tewari, A. K., & Sonker, P. (2026). TPGS-stabilized pyrimethamine micelles promote ROS-associated apoptosis in MDA-MB-231 cells and suppress tumour progression in a murine lymphoma model. DARU Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-026-00656-4

Vancouver

Yadav I, Nidhar M, Goud P, Pandey SN, Patel A, Tewari AK, et al. TPGS-stabilized pyrimethamine micelles promote ROS-associated apoptosis in MDA-MB-231 cells and suppress tumour progression in a murine lymphoma model. DARU Journal of Pharmaceutical Sciences. 2026. doi:10.1007/s40199-026-00656-4

BibTeX
@article{Yadav2026,
  author = {Yadav, Indrajeet and Nidhar, Manisha and Goud, Pavan and Pandey, Surya Nath and Patel, Amit and Tewari, Ashish Kumar and Sonker, Priyanka},
  title = {TPGS-stabilized pyrimethamine micelles promote ROS-associated apoptosis in MDA-MB-231 cells and suppress tumour progression in a murine lymphoma model},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2026},
  doi = {10.1007/s40199-026-00656-4}
}
Kostenlos starten →